Jansen T L Th A
Department of Rheumatology, Medical Centre Leeuwarden, P.O. Box 888, 8901 BR Leeuwarden, The Netherlands.
Int J Rheumatol. 2009;2009:286951. doi: 10.1155/2009/286951. Epub 2009 Mar 29.
A study was performed of consecutive patients presenting to a Dutch early arthritis clinic with a primary suggested diagnosis of reactive arthritis due to streptococci between April 1998 and January 2003, in a well-defined reference population consisting of 600 000 inhabitants. At 1 year after presentation out of 45 acute arthritis patients with initially an elevated antistreptolysin-O and without an alternative rheumatic diagnosis only 9 patients (20%) were not diagnosed as PSRA; 16 cases (36%) were due to NGAS, 20 cases (44%) due to GAS. The estimate of the annual incidence rate of PSRA in the Netherlands during the study was 1.26 per 100 000: 0.70 GAS-related. A diagnostic set of criteria was formulated based on the original Ayoub&Ahmed criteria by adding a serological criterium ASO/antiDNaseB ratio <1.4 and excluding a clinical criterium on chronicity/recurrency of arthritis: likelihood ratio for a positive test 7.9 [95% confidence interval (95%CI: 2.7-22.7)], for a negative test 0.06 [95%CI: 0.009-0.39].
对1998年4月至2003年1月间连续就诊于荷兰一家早期关节炎诊所、初步诊断为链球菌感染反应性关节炎的患者进行了一项研究,该研究在一个由60万居民组成的明确参考人群中开展。就诊1年后,在45例初始抗链球菌溶血素O升高且无其他风湿性诊断的急性关节炎患者中,只有9例(20%)未被诊断为PSRA;16例(36%)由NGAS引起,20例(44%)由GAS引起。研究期间荷兰PSRA的年发病率估计为每10万人中1.26例:其中0.70例与GAS相关。基于最初的Ayoub&Ahmed标准制定了一套诊断标准,增加了血清学标准ASO/抗DNaseB比值<1.4,并排除了关于关节炎慢性/复发性的临床标准:阳性检测的似然比为7.9 [95%置信区间(95%CI:2.7 - 22.7)],阴性检测的似然比为0.06 [95%CI:0.009 - 0.39]。